RxSight (RXST) Stock Chart & Stock Price History $26.67 +2.30 (+9.44%) Closing price 04:00 PM EasternExtended Trading$26.46 -0.21 (-0.77%) As of 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RxSight Stock Price Performance 5 Day Performance+7.37%1 Month Performance-5.46%3 Month Performance-22.06%6 Month Performance-45.06%Year-To-Date Performance-22.43%1 Year Performance-47.37% Receive RXST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. Email Address RXST Stock Chart for Thursday, March, 27, 2025 RXST Chart by TradingViewRemove Ads RxSight Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2025$24.37$26.67+9.44%$27.13$24.24860,634 shs$1.08 billion03/26/2025$24.70$24.37-1.34%$25.12$24.31280,169 shs$986.77 million03/25/2025$24.92$24.70-0.88%$25.19$24.62347,443 shs$1.00 billion03/24/2025$24.84$24.92+0.32%$25.50$24.76504,488 shs$1.01 billion03/21/2025$24.90$24.84-0.24%$24.87$24.09594,203 shs$1.01 billion03/20/2025$24.85$24.90+0.20%$25.26$24.38639,144 shs$1.01 billion03/19/2025$25.73$24.85-3.42%$25.70$24.77661,227 shs$1.01 billion03/18/2025$26.50$25.73-2.91%$26.65$25.59531,395 shs$1.04 billion03/17/2025$25.84$26.50+2.55%$26.54$25.69408,685 shs$1.07 billion03/14/2025$25.22$25.84+2.46%$25.96$25.11437,280 shs$1.05 billion Get the Latest News and Ratings for RXST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. 03/13/2025$26.07$25.22-3.26%$26.20$25.11291,254 shs$1.02 billion03/12/2025$25.44$26.07+2.48%$26.79$25.20606,512 shs$1.06 billion03/11/2025$24.76$25.44+2.75%$25.89$24.68546,364 shs$1.03 billion03/10/2025$25.10$24.76-1.35%$25.87$24.64936,754 shs$1.00 billion03/07/2025$25.56$25.10-1.80%$26.22$24.79792,495 shs$1.02 billion03/06/2025$26.59$25.56-3.87%$26.82$25.54745,093 shs$1.03 billion03/05/2025$26.86$26.59-1.01%$27.08$26.32361,499 shs$1.08 billion03/04/2025$26.93$26.86-0.26%$27.33$26.17522,343 shs$1.09 billion03/03/2025$28.36$26.93-5.04%$29.00$26.78444,781 shs$1.09 billion02/28/2025$28.21$28.36+0.53%$28.54$27.35620,965 shs$1.14 billion02/27/2025$28.97$28.21-2.62%$29.69$28.04723,343 shs$1.14 billion02/26/2025$29.21$28.97-0.82%$29.10$27.001.60 million shs$1.17 billion Related Companies PROCEPT BioRobotics Stock Price Chart iRhythm Technologies Stock Price Chart Envista Stock Price Chart TransMedics Group Stock Price Chart Soleno Therapeutics Stock Price Chart Enovis Stock Price Chart LivaNova Stock Price Chart NovoCure Stock Price Chart Warby Parker Stock Price Chart LeMaitre Vascular Stock Price Chart Receive RXST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RXST) was last updated on 3/27/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
